Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Tilray Medical, a division of Tilray Brands (NASDAQ:TLRY), announced the launch of its first commercial medical cannabis products cultivated in Germany.
The debut comes from its Aphria RX facility, marking a milestone under the country’s recently updated cultivation regulations, MedCanG.
New Cultivation License Drives Local Production
Tilray was the first company to secure the new cannabis cultivation license under MedCanG in July 2024.
This regulatory shift allows Aphria RX to grow and manufacture a variety of popular medical cannabis strains that were previously imported.
The indoor-grown products are expected to offer consistent quality tailored to German patients’ preferences:
“Our Made in Germany premium …